National Institutes of Health (NIH)

Program links academic institutions developing best practices to translate biomedical innovations into public benefit.

Redesigned MRI holds promise for the diagnosis and treatment of diseases.

Ninety-three awards will fund highly innovative, high-impact biomedical research.

The parasite, however, does not respond to treatment with standard leishmaniasis drugs.

Expanded open science will advance the pipeline for innovative therapeutics

‘Forward-oriented’ design might boost treatment effectiveness and broaden use.

Recipients living with HIV show no indication of secondary infection with donor HIV strain.

Deferring drug until after delivery is safer, NIH-funded trial finds.

New grants aimed at better understanding diseases, moving potential treatments closer to the clinic.

Pages